NHANES I | 84 | 2.95 (2.62 to 3.33) | 1.29 (1.21 to 1.39) | 1.05 (0.97 to 1.13) | 2.08 (1.67 to 2.58) | 2.50 (1.89 to 3.30) |
NHANES II | 80 | 2.84 (2.28 to 3.55) | 1.35 (1.21 to 1.50) | 1.17 (1.05 to 1.30) | 1.92 (1.38 to 2.69) | 2.76 (1.92 to 3.97) |
Framingham cohort | 86 | 2.26 (1.72 to 2.97) | 1.60 (1.32 to 1.93) | 1.41 (1.17 to 1.69) | 1.80 (1.14 to 2.82) | 4.67 (2.70 to 8.07) |
Tecumseh community health study | 88 | 2.71 (2.08 to 3.53) | 1.48 (1.27 to 1.73) | 1.14 (0.94 to 1.37) | 1.93 (1.09 to 3.38) | 1.32 (0.62 to 2.82) |
Renfrew and Paisley study | 76 | 2.68 (2.26 to 3.17) | 1.34 (1.27 to 1.43) | 1.20 (1.12 to 1.29) | 2.07 (1.75 to 2.45) | 3.65 (2.36 to 5.65) |
Norwegian counties study | 72 | 1.71 (1.10 to 2.65) | 1.72 (1.51 to 1.96) | 1.37 (1.26 to 1.49) | 3.01 (2.11 to 4.28) | 8.67 (3.81 to 19.77) |
Iceland Reykjavik study | 83 | 2.84 (2.39 to 3.38) | 1.45 (1.32 to 1.60) | 1.31 (1.20 to 1.43) | 3.34 (2.60 to 4.28) | 3.81 (2.25 to 6.44) |
HDFP (regular care) | 79 | 2.74 (1.92 to 3.92) | 1.19 (0.99 to 1.44) | 1.30 (1.17 to 1.44) | 1.87 (1.10 to 3.18) | 2.57 (1.37 to 4.81) |